I still like the co
Almost no debt, growing revenue, generating cash flow, breaking into the US market.
Their approach to writing off R&D costs I believe is prudent even with the P&L volatility created.
If they generate a decent market share in the US this could rocket provided it is not at the cost of the current markets.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.1M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 33.0¢ | $12.46K | 37.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 7000 | 1 |
View Market Depth
| Last trade - 15.42pm 15/07/2025 (20 minute delay) ? |
| AHC (ASX) Chart |